Recombinant PTK7 (Cofetuzumab Biosimilar) antibody (PE)

Catalog No. ABIN7829444

The Humanized Monoclonal anti-PTK7 (Cofetuzumab Biosimilar) antibody is suitable to detect PTK7 (Cofetuzumab Biosimilar) in samples from Human. It has been validated for FACS.

Quick Overview for Recombinant PTK7 (Cofetuzumab Biosimilar) antibody (PE) (ABIN7829444)

Target: PTK7 (Cofetuzumab Biosimilar)

Antibody Type: Recombinant Antibody

Reactivity: Human

Host: Humanized

Clonality: Monoclonal

Conjugate: This PTK7 (Cofetuzumab Biosimilar) antibody is conjugated to PE

Application: Flow Cytometry (FACS)

Grade: Research Grade

Product Details anti-PTK7 (Cofetuzumab Biosimilar) Antibody (PE)

Purpose: PE-conjugated Anti-PTK7(cofetuzumab biosimilar) mAb

Isotype: E356D, IgG1, M358L, kappa

Application Details

Application Notes: Flow Cyt 1 μL:test

Comment:

Research grade biosimilar. Not for use in therapeutic or diagnostic procedures for humans or animals.

Restrictions: For Research Use only

Handling

Format: Liquid

Buffer: Liquid,PBS with,0.18 % BSA,0.1 %Proclin300

Preservative: ProClin

Precaution of Use: This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Storage: 4 °C

Storage Comment: Store at 2°C-8°C for 6 months

Expiry Date: 6 months

Target Details for PTK7 (Cofetuzumab Biosimilar)

Target: PTK7 (Cofetuzumab Biosimilar)

Alternative Name: Cofetuzumab Biosimilar

Target Type: Biosimilar

Background: Synonyms Target:CCK4
Synonyms Antibody:PF-06523435,hu24

UniProt: Q13308